Arrakis Therapeutics vs Nexo Therapeutics
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients
52 employees · est. 2015 · Waltham, United States
Nexo Therapeutics
We’re driven to translate the most compelling and still undrugged targets in human biology into medicines for patients
19 employees · est. 2022 · Watertown, United States
Arrakis Therapeutics is the older company (2015 vs 2022); Arrakis Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Arrakis Therapeutics | Nexo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2022 |
| Headquarters | ||
| Headquarters | Waltham, United States | Watertown, United States |
| Employees | ||
| Employees | 52 larger | 19 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | $115.00M | $60.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | RNA-targeted Small Molecule Development, Pipeline Management, Biotech Research and Development, Oral Medicines Development | Chemical Biology R&D, Covalent Drug Design, Biomedical Research, Biotech Innovations |
| Target Customers | ||
| Target Customers | Patients with Myotonic Dystrophy Type 1, Healthcare Providers, Biopharma Partners, Medical Researchers | Pharmaceutical Companies, Biotech Researchers, Healthcare Institutions, Drug Development Firms |
| Taxonomy | ||
| Taxonomy | RNA-targeted TherapiesSmall-molecule MedicinesDrug DiscoveryRNA BioinformaticsRNA Structural ToolsNeurology +7 | OncologyCancer TherapySmall Molecule DrugsCovalent Ligand DiscoveryChemical BiologyCancer Biology +7 |
| Website | ||
| Website | arrakistx.com | nexotx.com |
About Arrakis Therapeutics
Arrakis Therapeutics is a pioneering player in the Biopharma and Biotechnology sector, headquartered in the United States. Founded in 2015, the company is on an ambitious mission to leverage RNA-targeted small molecule (rSM) therapies to revolutionize patient care. Their innovative approach adapts t...
About Nexo Therapeutics
Nexo Therapeutics, founded in 2022, is a dynamic player in the Biotechnology and Life Sciences industries, based in the United States. The company is committed to creating innovative small molecule therapies targeting cancer, particularly for patients lacking substantial treatment options. This alig...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Arrakis Therapeutics and Nexo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Arrakis Therapeutics or Nexo Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Arrakis Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Arrakis Therapeutics on 15 Jun 2026, and Nexo Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
